Moderna(us:MRNA)
39.27
-0.30%
Updated on 2024-12-23
Open:39.30
Close:39.27
High:40.34
Low:38.52
Pre Close:39.39
Volume:3.37M
Amount:133.32M
Turnover:0.88%
Shares:384.82M
MarketCap:15.11B
About Moderna Company
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Company Name: Moderna
Company Address: 325 Binney Street
Employees: 5600
Fiscar Year: 12-31
IPO Date: 2018-12-07
Website: http://www.modernatx.com
CIK: 1682852
View all SEC Filings
About
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Address:325 Binney Street
Website:http://www.modernatx.com
Market Movers